Nicola Crosetto
Principal Researcher
E-mail: nicola.crosetto@ki.se
Telephone: +46852485258
Visiting address: Solnavägen 9, Biomedicum, 17165 Solna
Postal address: C1 Mikrobiologi, tumör- och cellbiologi, C1 MTC Bienko, 171 77 Stockholm
About me
- I graduated in Medicine at the University of Pavia, Italy in 2003 and specialized in Medical Oncology at the University of Turin, Italy in 2007. From 2008 until 2010, I worked in Ivan Dikic’s lab at the Goethe University in Frankfurt, Germany and in 2011 I obtained a PhD in Bioengineering and Bioinformatics at the University of Pavia, Italy. From 2011 until 2014 I was a postdoc in Alexander van Oudenaarden’s lab at MIT, where I worked on developing novel single-molecule microscopy methods. Since 2015, I have been leading my own research group at Karolinska Institutet, with a major focus on developing microscopy- and sequencing-based methods to investigate genome fragility and genome organization in healthy and pathological cell states. Since 2022 I also lead the Genomic Technologies Development Unit in the Genomics Research Centre at Human Technopole in Milan, Italy.Over the years, I have developed numerous molecular methods, including the first method for genome-wide mapping of DNA double-strand breaks (BLESS, /Nat Meth/ 2013) and its downstream improvements (BLISS, /Nat Commun/ 2017
- sBLISS, /Nat Prot/ 2020), as well as a variety of sequencing- (CUTseq, /Nat Commun/ 2019
- GPSeq, /Nat Biotechnol/ 2020
- COVseq, /Nat Commun/ 20221) and microscopy-based methods (HD-FISH, /Nat Meth/ 2013
- FuseFISH, /Cell Rep/ 2014
- RollFISH, /Comm Bio/ 2018
- iFISH, /Nat Commun/ 2019
- FRET-FISH, /Nat Commun/ 2022) for studying various aspects of genome organization and fragility.
Research
- Our main research interest is in understanding how the nucleus of eukaryotic cells is spatially organized, and how the three-dimensional (3D) architecture of the genome influences gene expression regulation and genome integrity.We are particularly interested in understanding the role of 3D genome architecture and genome fragility in the context of cancer, aiming at developing improved diagnostic and patient stratification approaches.Towards these goals, we combine high-end microscopy methods, next-generation sequencing techniques, and advanced computational tools, to assess chromosomal contacts, chromatin modifications, DNA breaks, chromosomal rearrangements and gene expression levels in cultured cells and patient-derived tissue samples.
Articles
-
Article: CURRENT OPINION IN GENETICS & DEVELOPMENT. 2023;78:102020
-
Article: JTO CLINICAL AND RESEARCH REPORTS. 2022;3(12):100435
-
Article: NATURE COMMUNICATIONS. 2022;13(1):6680
-
Article: BMC CANCER. 2022;22(1):1001
-
Article: GENOME MEDICINE. 2022;14(1):98
-
Article: SCIENTIFIC DATA. 2022;9(1):400
-
Article: SCIENTIFIC DATA. 2022;9(1):47
-
Article: CURRENT OPINION IN CELL BIOLOGY. 2022;74:7-12
-
Article: MOLECULAR CELL. 2021;81(24):5007-5024.e9
-
Article: MOLECULAR CELL. 2021;81(23):4907-4923.e8
-
Article: NATURE COMMUNICATIONS. 2021;12(1):3903
-
Article: VACCINES. 2021;9(3):235
-
Article: METHODS IN MOLECULAR BIOLOGY. 2021;2162:261-281
-
Article: FRONTIERS IN ONCOLOGY. 2021;11:700568
-
Article: NATURE PROTOCOLS. 2020;15(12):3894-3941
-
Article: NATURE BIOTECHNOLOGY. 2020;38(10):1184-1193
-
Article: NATURE MEDICINE. 2020;26(7):1063-1069
-
Article: NATURE COMMUNICATIONS. 2019;10(1):4732
-
Article: CELL REPORTS. 2019;29(3):560-572.e4
-
Article: MOLECULAR CELL. 2019;75(2):267-283.e12
-
Article: NATURE GENETICS. 2019;51(6):1011-1023
-
Article: NATURE COMMUNICATIONS. 2019;10(1):1636
-
Article: GENOME BIOLOGY. 2019;20(1):28
-
Article: CELL. 2018;173(4):879-893.e13
-
Article: COMMUNICATIONS BIOLOGY. 2018;1:209
-
Article: COMMUNICATIONS BIOLOGY. 2018;1:181
-
Article: METHODS IN MOLECULAR BIOLOGY. 2018;1672:167-194
-
Article: METHODS IN MOLECULAR BIOLOGY. 2018;1766:303-333
-
Article: NATURE COMMUNICATIONS. 2017;8(1):374
-
Article: NATURE COMMUNICATIONS. 2017;8(1):228
-
Article: NATURE BIOTECHNOLOGY. 2017;35(8):789-792
-
Article: NATURE COMMUNICATIONS. 2017;8:15656
-
Article: NATURE COMMUNICATIONS. 2017;8:15058
-
Article: BLOOD. 2017;129(18):2479-2492
-
Article: ONCOTARGET. 2017;8(12):18680-18698
-
Article: NATURE BIOTECHNOLOGY. 2016;34(8):852-856
-
Article: NATURE MEDICINE. 2016;22(3):270-277
-
Article: BLOOD CANCER JOURNAL. 2014;4(10):e249
-
Article: JOURNAL OF TISSUE ENGINEERING AND REGENERATIVE MEDICINE. 2014;8(5):396-406
-
Article: CELL REPORTS. 2014;6(1):18-23
-
Article: NATURE METHODS. 2013;10(4):361-365
-
Article: NATURE METHODS. 2013;10(2):122-124
-
Article: ONCOGENE. 2012;31(43):4599-4608
-
Article: CARDIOVASCULAR TOXICOLOGY. 2012;12(2):135-142
-
Article: JOURNAL OF PROTEOME RESEARCH. 2011;10(5):2140-2153
-
Article: ANNALS OF ONCOLOGY. 2011;22(3):712-717
-
Article: CELL. 2010;143(5):677-681
-
Article: MOLECULAR CELL. 2010;37(3):396-407
-
Article: INTERNATIONAL JOURNAL OF DEVELOPMENTAL BIOLOGY. 2010;54(11-12):1649-1657
-
Article: JOURNAL OF BIOLOGICAL CHEMISTRY. 2008;283(50):35173-35185
-
Article: BLOOD. 2007;110(3):1004-1012
-
Article: EUROPEAN JOURNAL OF CANCER. 2006;42(18):3095-3102
-
Article: NATURE CELL BIOLOGY. 2006;8(2):163-169
-
Article: SCIENCE. 2005;310(5755):1821-1824
-
Article: JOURNAL OF BIOLOGICAL CHEMISTRY. 2004;279(31):32786-32795
-
Article: LEUKEMIA. 2003;17(11):2107-2112
-
Article: BRITISH JOURNAL OF HAEMATOLOGY. 2002;118(2):545-549
- Show more
All other publications
-
Editorial comment: NATURE METHODS. 2023;20(5):641-642
-
Review: TRENDS IN GENETICS. 2022;38(10):1062-1075
-
Editorial comment: TUMORI JOURNAL. 2020;106(5):427-431
-
Review: FRONTIERS IN GENETICS. 2020;11:33
-
Review: FRONTIERS IN ONCOLOGY. 2020;10:569202
-
Review: GENES. 2018;9(12):E632-632
-
Corrigendum: METHODS IN MOLECULAR BIOLOGY. 2018;1766:E1
-
Review: NATURE REVIEWS GENETICS. 2015;16(1):57-66
-
Editorial comment: INTERNATIONAL JOURNAL OF DEVELOPMENTAL BIOLOGY. 2008;52(7):801-809
-
Other: EUROPEAN JOURNAL OF HISTOCHEMISTRY. 2008;52(1):79-81
-
Review: MOLECULAR CANCER RESEARCH. 2006;4(12):899-904
-
Review: FEBS LETTERS. 2005;579(15):3231-3238